Literature DB >> 14605950

Expression of cyclooxygenase-1 and -2 in human breast cancer.

Norio Yoshimura1, Hajime Sano, Masahiko Okamoto, Kiyokazu Akioka, Hidetaka Ushigome, Yayoi Kadotani, Rikio Yoshimura, Shuji Nobori, Atsushi Higuchi, Yoshihiro Ohmori, Kenji Nakamura.   

Abstract

PURPOSE: We investigated the expression of cyclooxygenase (Cox-1 and Cox-2) in mammary tissues from patients with breast cancer.
METHODS: We used reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry.
RESULTS: The cancer cells showed very weak expression of Cox-1, but strong expression of immunoreactive Cox-2. In contrast, immunoreactive Cox-2 was very weak in all of the benign mammary tumors examined, including fibroadenoma (FA) and mastopathy (MP). Immunoreactive Cox-1 was also very weak in these benign tumors. The extent and intensity of immunoreactive Cox-2 polypeptides was significantly greater in the cancer cells than in the FA cells or MP cells. RT-PCR analysis showed enhanced expression of Cox-2, but not Cox-1 in breast cancer tissue, and faint expression of Cox-2 in benign tissue.
CONCLUSIONS: These results demonstrated that human breast cancer cells generated Cox-2, indicating that Cox-2 might play an important role in the proliferation of breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605950     DOI: 10.1007/s00595-003-2606-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

Review 1.  Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.

Authors:  Onder Onguru; Mary B Casey; Sabine Kajita; Nobuki Nakamura; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Mechanism and clinical significance of cyclooxygenase-2 expression in gastric cancer.

Authors:  Bao-Can Wang; Chang-Qing Guo; Chao Sun; Qiao-Ling Sun; Guo-Yong Liu; Ding-Guo Li
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

Review 3.  Role of Aspirin in Breast Cancer Survival.

Authors:  Wendy Y Chen; Michelle D Holmes
Journal:  Curr Oncol Rep       Date:  2017-07       Impact factor: 5.075

4.  Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer.

Authors:  Jun Tian; Mahmood Y Hachim; Ibrahim Y Hachim; Meiou Dai; Chieh Lo; Fatmah Al Raffa; Suhad Ali; Jean Jacques Lebrun
Journal:  Sci Rep       Date:  2017-01-05       Impact factor: 4.379

Review 5.  The tumor microenvironment and inflammatory breast cancer.

Authors:  Aji Huang; Shousong Cao; Lili Tang
Journal:  J Cancer       Date:  2017-07-03       Impact factor: 4.207

Review 6.  Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer.

Authors:  Riley J Morrow; Nima Etemadi; Belinda Yeo; Matthias Ernst
Journal:  Mediators Inflamm       Date:  2017-05-14       Impact factor: 4.711

7.  Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer.

Authors:  Sandrine Tury; Véronique Becette; Franck Assayag; Sophie Vacher; Camille Benoist; Maud Kamal; Elisabetta Marangoni; Ivan Bièche; Florence Lerebours; Céline Callens
Journal:  Oncotarget       Date:  2016-12-20

Review 8.  Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer.

Authors:  Louise R Howe
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

9.  COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ.

Authors:  Swati Kulkarni; Deepa B Patil; Leslie K Diaz; Elizabeth L Wiley; Monica Morrow; Seema A Khan
Journal:  BMC Cancer       Date:  2008-01-31       Impact factor: 4.430

10.  Aspirin and breast cancer prevention--a link to ER status.

Authors:  Catherine R Tait
Journal:  Breast Cancer Res       Date:  2004-08-09       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.